Close Menu

Thomas Insel, director of the National Institute of Mental Health, says that genomics has been an "area of unambiguous progress" for schizophrenia research during the last few years. At his blog, Insel highlights how genomics researchers have identified several genes associated with schizophrenia risk, which are "not the usual suspects," he says.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.

A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.

In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.